A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue

Myeloma is characterized by a highly variable clinical outcome. Despite the effectiveness of high-dose therapy, 15% of patients relapse within 1 year. We show that these cases also have a significantly shorter post-relapse survival compared to the others (median 14.9 months vs. 40 months, p = 8.03 ×...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ping, Walker, Brian A., Broyl, Annemiek, Kaiser, Martin, Johnson, David C., Kuiper, Rowan, van Duin, Mark, Gregory, Walter M., Davies, Faith E., Brewer, Daniel, Hose, Dirk, Sonneveld, Pieter, Morgan, Gareth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Articles: Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444991/
https://www.ncbi.nlm.nih.gov/pubmed/24913504
http://dx.doi.org/10.3109/10428194.2014.911863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444991/
https://www.ncbi.nlm.nih.gov/pubmed/24913504
http://dx.doi.org/10.3109/10428194.2014.911863

Ejemplares similares